Mp64-20 Opioid-Free Pathway After Reconstructive Surgery Does Not Generate Additional Patient Calls

You have accessJournal of UrologyReconstruction: External Genitalia and Urotrauma (Including Transgender Surgery and Traumatic Fistula) II (MP64)1 May 2024MP64-20 OPIOID-FREE PATHWAY AFTER RECONSTRUCTIVE SURGERY DOES NOT GENERATE ADDITIONAL PATIENT CALLS Samantha R. Freeman, Rachel A. Mann, and Alex J. Vanni Samantha R. FreemanSamantha R. Freeman , Rachel A. MannRachel A. Mann , and Alex J. VanniAlex J. Vanni View All Author Informationhttps://doi.org/10.1097/01.JU.0001008824.92877.7f.20AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Prior studies have demonstrated that even small quantities of opioids prescribed for acute pain following surgery can contribute to addiction, and opioid-related side effects can complicate recovery. The objective of our study was to determine whether patients undergoing reconstructive surgery on an opioid free pathway resulted in more pain related patient phone calls. METHODS: An opioid free post-operative pathway was instituted at our institution in 2019. A case-cohort study was performed; patients who had an artificial urinary sphincter (AUS) placement, urethroplasty, or buried penis repair (BPR) were identified from 2015-2023. Demographic, surgical, and post-operative data were collected by retrospective chart review. Patient phone calls related to pain were tracked for 30 days following the index surgery (pre/post opioid free pathway). Statistical significance was determined using an unpaired t-test for continuous variables and a chi-squared test for categorical variables. Patients were excluded if they underwent another surgery concurrently or had a pre-operative opioid prescription. RESULTS: A total of 360 patients were included, with 84 undergoing BPR, 140 undergoing urethroplasty, and 132 undergoing AUS insertion. There were no significant demographic differences between patients who received opioids versus those who did not. Amongst all patients in the non-opioid group, only 7 patients (3.9%) received an opioid within 30 days post-operatively. There was no significant difference in the number of patients with pain-related calls in the opioid versus non-opioid groups, regardless of surgery type (Table 1). Amongst patients who underwent BPR and received an opioid prescription, they were twice as likely to call reporting pain, however this did not reach statistical significance. Of those who called, 25.8% of patients in the opioid group received a refill, while 30.5% of opioid naïve patients received a first-time opioid prescription (p=0.26). CONCLUSIONS: An opioid free pathway can be performed for the vast majority of urethroplasty, buried penis, and AUS patients without an increase in pain related phone calls. Source of Funding: N/A © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e1049 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Samantha R. Freeman More articles by this author Rachel A. Mann More articles by this author Alex J. Vanni More articles by this author Expand All Advertisement PDF downloadLoading ...